Botox maker sees surge in profits Pre-tax profits at Botox producer, Allergan Pharmaceuticals Ireland increased by 24% to $232.5 million last year. Business • 16 Nov 20
AbbVie reports loss as Covid-19 hits Botox sales Drugmaker AbbVie has today reported a loss in the second quarter, as comparable sales from wrinkle treatment Botox, acquired as part of its $63 billion … Business • 31 Jul 20
Allergan opens new €160m biologics plant in Westport Allergan, the maker of Botox, is opening a new €160m biologics facility at its campus in Westport in Co Mayo. Business • 28 Jan 20
Irish profits sagged at Botox maker Allergan last year Pre-tax profits at Co Mayo-based Botox producer, Allergan Pharmaceuticals Ireland last year declined by 17% to $187m (€168.69m) Business • 04 Dec 19
Allergan shareholders give AbbVie takeover green light Shareholders at Dublin headquartered Botox-maker Allergan have strongly backed its $63bn takeover by US pharmaceutical company AbbVie. Business • 14 Oct 19
AbbVie to buy Botox-maker Allergan in $63 billion deal AbbVie said today it would buy Botox-maker Allergan in a cash-and-stock deal for about $63 billion to add fast-growing therapeutic businesses such as medical aesthetics … Business • 25 Jun 19
Allergan raises 2019 forecasts as Botox boosts results Allergan today raised its profit and revenue forecasts for the year as it beat expectations for quarterly profit, fueled by higher sales of its blockbuster … Business • 07 May 19
163 new Connacht jobs in wedding, botox companies A wedding planning company is to create 100 jobs in Galway, while a further 63 jobs have been announced for Mayo plant Allergan. Connacht • 29 Apr 19
Allergan tops profit estimates on Botox sales Allergan today topped analysts' estimates for quarterly profit and raised its forecast for annual earnings, led by stronger demand for medical aesthetic products including Botox. Business • 26 Jul 18
Botox-maker Allergan quarterly revenue rises 2.8% Botox maker Allergan today reported a better-than-expected quarterly profit and raised its full-year forecast for adjusted net income. Business • 30 Apr 18
Allergan posts quarterly profit ahead of estimates Botox-maker Allergan has reported adjusted profit that beat analysts' estimates, and raised its 2017 forecast to include its $2.48 billion acquisition of Zeltiq Aesthetics. Business • 09 May 17
Allergan reports 48% rise in quarterly revenues Allergan, whose $160 billion merger with Pfizer fell apart last month, today reported a better than expected quarterly profit today, led by strong sales of … Business • 10 May 16
Allergan agrees to Actavis deal for $66 billion Allergan has agreed to be bought by Actavis for $66 billion, putting an end to a hostile bid by activist investor William Ackman and Valeant … Business • 17 Nov 14
Valeant injects cash into bid for Botox maker Valeant Pharmaceuticals International has raised the cash component of its unsolicited offer for Botox-maker Allergan. Business • 28 May 14
Botox maker Allergan rejects takeover bid Allergan, the US maker of Botox, has rejected a takeover bid from Valeant Pharmaceuticals, saying it "substantially undervalues" the company and questioning the Canadian firm's … Business • 12 May 14
Ackman and Valeant team up to bid for Allergan Activist investor William Ackman teamed up with Canada's Valeant Pharmaceuticals International to make a joint run at buying Allergan. Business • 22 Apr 14
